Cott (TSE:PRM) Stock Rating Upgraded by BMO Capital Markets

Cott (TSE:PRM) was upgraded by investment analysts at BMO Capital Markets to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports.

Several other analysts have also recently commented on PRM. William Blair upgraded shares of Cott to a “strong-buy” rating in a research note on Thursday, October 24th. Raymond James downgraded Cott from a “moderate buy” rating to a “hold” rating in a research report on Wednesday, October 2nd.

Cott Stock Up 0.7 %

Shares of PRM stock opened at C$13.39 on Monday. The stock has a fifty day moving average price of C$13.26. Cott has a 1 year low of C$12.95 and a 1 year high of C$14.97.

About Cott

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.